Kanaph Therapeutics카나프테라퓨틱스
0082N0 · KOSDAQ · ₩0082N0 · 카나프테라퓨틱스
₩9,100▼ ₩550 (5.70%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | |
|---|---|---|
| Revenue | ₩75M | ₩78M |
| Operating income | −₩4.7B | −₩5.4B |
| Net income | −₩4.3B | −₩5.3B |
| Net income to shareholders | −₩4.3B | −₩5.3B |
Balance sheet
| Q2 2026 | Q1 2026 | |
|---|---|---|
| Total assets | ₩48B | ₩52B |
| Current assets | ₩47B | ₩50B |
| Cash and equivalents | ₩10B | ₩12B |
| Total liabilities | ₩2B | ₩2.2B |
| Current liabilities | ₩1.3B | ₩1.5B |
| Total equity | ₩46B | ₩49B |
| Shareholders' equity | ₩46B | ₩49B |
Cash flow
| Q2 2026 | Q1 2026 | |
|---|---|---|
| Cash from operations | −₩4.7B | −₩1.4B |
| Capital spending | ₩36M | ₩11M |
| Free cash flow | −₩4.8B | −₩1.4B |
Consolidated where available. Amounts in won.
Also known as: Kanaph Therapeutics / 카나프테라퓨틱스 / 0082N0 / KRX:0082N0
Source: KRX statistical information